215 related articles for article (PubMed ID: 23568327)
1. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.
Joh HK; Giovannucci EL; Bertrand KA; Lim S; Cho E
J Natl Cancer Inst; 2013 May; 105(10):726-32. PubMed ID: 23568327
[TBL] [Abstract][Full Text] [Related]
2. Commentary on "Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer." Joh HK, Giovannucci EL, Bertrand KA, Lim S, Cho E, Department of Medicine, Seoul National University College of Medicine, Seoul, South Korea. J Natl Cancer Inst 2013; 105(10):726-32. [Epub 2013 Apr 8]. doi: 10.1093/jnci/djt082.
Boorjian S
Urol Oncol; 2014 Aug; 32(6):933-4. PubMed ID: 25087670
[TBL] [Abstract][Full Text] [Related]
3. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group and risk of renal cell cancer.
Joh HK; Cho E; Choueiri TK
Cancer Epidemiol; 2012 Dec; 36(6):528-32. PubMed ID: 22841339
[TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
Johansson M; Fanidi A; Muller DC; Bassett JK; Midttun Ø; Vollset SE; Travis RC; Palli D; Mattiello A; Sieri S; Trichopoulou A; Lagiou P; Trichopoulos D; Ljungberg B; Hallmans G; Weiderpass E; Skeie G; González CA; Dorronsoro M; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Boutron Ruault MC; Fagherazzi G; Clavel F; Sánchez MJ; Gurrea AB; Navarro C; Quiros JR; Overvad K; Tjønneland A; Aleksandrova K; Vineis P; Gunter MJ; Kaaks R; Giles G; Relton C; Riboli E; Boeing H; Ueland PM; Severi G; Brennan P
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376861
[TBL] [Abstract][Full Text] [Related]
6. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.
Ananthakrishnan AN; Khalili H; Higuchi LM; Bao Y; Korzenik JR; Giovannucci EL; Richter JM; Fuchs CS; Chan AT
Gastroenterology; 2012 Mar; 142(3):482-9. PubMed ID: 22155183
[TBL] [Abstract][Full Text] [Related]
7. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies.
Lee JE; Spiegelman D; Hunter DJ; Albanes D; Bernstein L; van den Brandt PA; Buring JE; Cho E; English DR; Freudenheim JL; Giles GG; Graham S; Horn-Ross PL; Håkansson N; Leitzmann MF; Männistö S; McCullough ML; Miller AB; Parker AS; Rohan TE; Schatzkin A; Schouten LJ; Sweeney C; Willett WC; Wolk A; Zhang SM; Smith-Warner SA
J Natl Cancer Inst; 2008 Dec; 100(23):1695-706. PubMed ID: 19033572
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
Giovannucci E; Liu Y; Rimm EB; Hollis BW; Fuchs CS; Stampfer MJ; Willett WC
J Natl Cancer Inst; 2006 Apr; 98(7):451-9. PubMed ID: 16595781
[TBL] [Abstract][Full Text] [Related]
10. Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition.
Rohrmann S; Linseisen J; Overvad K; Lund Würtz AM; Roswall N; Tjonneland A; Boutron-Ruault MC; Racine A; Bastide N; Palli D; Agnoli C; Panico S; Tumino R; Sacerdote C; Weikert S; Steffen A; Kühn T; Li K; Khaw KT; Wareham NJ; Bradbury KE; Peppa E; Trichopoulou A; Trichopoulos D; Bueno-de-Mesquita HB; Peeters PH; Hjartåker A; Skeie G; Weiderpass E; Jakszyn P; Dorronsoro M; Barricarte A; Santiuste de Pablos C; Molina-Montes E; de la Torre RA; Ericson U; Sonestedt E; Johansson M; Ljungberg B; Freisling H; Romieu I; Cross AJ; Vergnaud AC; Riboli E; Boeing H
Int J Cancer; 2015 Mar; 136(5):E423-31. PubMed ID: 25258006
[TBL] [Abstract][Full Text] [Related]
11. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
[TBL] [Abstract][Full Text] [Related]
12. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
[TBL] [Abstract][Full Text] [Related]
13. Predicted vitamin D status and incidence of tooth loss and periodontitis.
Jimenez M; Giovannucci E; Krall Kaye E; Joshipura KJ; Dietrich T
Public Health Nutr; 2014 Apr; 17(4):844-52. PubMed ID: 23469936
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.
Schöttker B; Herder C; Rothenbacher D; Perna L; Müller H; Brenner H
Eur J Epidemiol; 2013 Mar; 28(3):267-75. PubMed ID: 23354985
[TBL] [Abstract][Full Text] [Related]
15. The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma.
Xu S; Song J; Zhang ZH; Fu L; Gao L; Xie DD; Yu DX; Xu DX; Sun GP
Sci Rep; 2019 Nov; 9(1):16719. PubMed ID: 31723229
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
17. Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.
Palmer JR; Gerlovin H; Bethea TN; Bertrand KA; Holick MF; Ruiz-Narvaez EN; Wise LA; Haddad SA; Adams-Campbell LL; Kaufman HW; Rosenberg L; Cozier YC
Breast Cancer Res; 2016 Aug; 18(1):86. PubMed ID: 27520657
[TBL] [Abstract][Full Text] [Related]
18. Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Gallicchio L; Moore LE; Stevens VL; Ahn J; Albanes D; Hartmuller V; Setiawan VW; Helzlsouer KJ; Yang G; Xiang YB; Shu XO; Snyder K; Weinstein SJ; Yu K; Zeleniuch-Jacquotte A; Zheng W; Cai Q; Campbell DS; Chen Y; Chow WH; Horst RL; Kolonel LN; McCullough ML; Purdue MP; Koenig KL
Am J Epidemiol; 2010 Jul; 172(1):47-57. PubMed ID: 20562187
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D is not associated with incident dementia or cognitive impairment: an 18-y follow-up study in community-living old men.
Olsson E; Byberg L; Karlström B; Cederholm T; Melhus H; Sjögren P; Kilander L
Am J Clin Nutr; 2017 Apr; 105(4):936-943. PubMed ID: 28202477
[No Abstract] [Full Text] [Related]
20. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study.
Messenger W; Nielson CM; Li H; Beer T; Barrett-Connor E; Stone K; Shannon J
Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):856-63. PubMed ID: 21466949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
